Patents by Inventor Alison E. Anastasio

Alison E. Anastasio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Haplotypes of the CD3E gene
    Publication number: 20040018493
    Abstract: Novel genetic variants of the CD3 Antigen, Epsilon Subunit (CD3E) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the CD3E gene. Compositions and methods for haplotyping and/or genotyping the CD3E gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
    Type: Application
    Filed: July 12, 2002
    Publication date: January 29, 2004
    Inventors: Alison E. Anastasio, Amir Kazemi, Michael Lachowicz, Vicente Pabon, Nisha Shah
  • Haplotypes of the TNFRSF1A gene
    Publication number: 20030165844
    Abstract: Novel genetic variants of the Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the TNFRSF1A gene. Compositions and methods for haplotyping and/or genotyping the TNFRSF1A gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
    Type: Application
    Filed: August 31, 2001
    Publication date: September 4, 2003
    Applicant: Genaissance Pharmaceuticals, Inc.
    Inventors: Alison E. Anastasio, Anne Chew, R. Rex Denton, Krishnan Nandabalan, Katie E. Parks, J. Claiborne Stephens
  • Haplotypes of the AGTR1 gene
    Patent number: 6521747
    Abstract: Novel genetic variants of the Angiotensin Receptor 1 (AGTR1) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the AGTR1 gene. Compositions and methods for haplotyping and/or genotyping the AGTR1 gene in an individual are also disclosed. Polynucleotides defined by the sequence of the haplotypes disclosed herein are also described.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: February 18, 2003
    Assignee: Genaissance Pharmaceuticals, Inc.
    Inventors: Alison E. Anastasio, Kevin Finkel, Beena Koshy, Helen Lee
  • Haplotypes of the AGTR1 gene
    Publication number: 20020182605
    Abstract: Novel genetic variants of the Angiotensin Receptor 1 (AGTR1) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the AGTR1 gene. Compositions and methods for haplotyping and/or genotyping the AGTR1 gene in an individual are also disclosed. Polynucleotides defined by the sequence of the haplotypes disclosed herein are also described.
    Type: Application
    Filed: May 30, 2001
    Publication date: December 5, 2002
    Applicant: Genaissance Pharmaceuticals, Inc.
    Inventors: Alison E. Anastasio, Kevin Finkel, Beena Koshy, Helen Lee